|
⚲
|
| Keyboard |
| Affinity Asset Advisors LLC
✚
|
|
|---|---|
| CRD # | 312788 |
| SEC # | 801-120744 |
| CIK # | 0001773195 |
| AUM | 1,691.1 M (2026-03-27) |
| Employees | 10 (70% Investors, 0% Brokers) |
| Phone | 646-481-3856 |
| Address | 450 Park Avenue New York, NY 10022 |
| Source | [IAPD] [EDGAR] [Website] [Twitter] |
| Total AUM ($M) |
|---|
| In the News | |
|---|---|
| Sat, 25 Jul 2026 | Affinity Asset Advisors LLC Reduces Holdings in MBX Biosciences, Inc. $MBX — MarketBeat |
| Sat, 25 Jul 2026 | Affinity Asset Advisors LLC Decreases Holdings in Jade Biosciences, Inc. $JBIO — MarketBeat |
| Sat, 25 Jul 2026 | Affinity Asset Advisors LLC Grows Position in iBio, Inc. $IBIO — MarketBeat |
| Sat, 25 Jul 2026 | Affinity Asset Advisors LLC Has $54.77 Million Position in Praxis Precision Medicines, Inc. $PRAX — MarketBeat |
| Sat, 25 Jul 2026 | Affinity Asset Advisors LLC Sells 150,000 Shares of Trevi Therapeutics, Inc. $TRVI — MarketBeat |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Apogee Therapeutics Inc | 108.2 | ||
| Xenon Pharmaceuticals Inc | 97.4 | ||
| Erasca Inc | 86.6 | ||
| Insmed Inc | 78.5 | ||
| Roivant Sciences Ltd | 77.6 | ||
| Aeglea Biotherapeutics Inc | 64.5 | ||
| Praxis Precision Medicines Inc | 54.8 | ||
| Anaptysbio Inc | 52.1 | ||
| Alkermes PLC | 47.7 | ||
| Cytokinetics Inc | 46.2 | ||
| View All | |||
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| VC | Affinity Healthcare Special CT II LP | [2022-03-28] | 7.5 M | 7.3 M |
| Filed 2022-01-10 (D) · Exemption 506(b), 3(c), 3(c)(1) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| HF | Affinity Healthcare Fund LP | [2021-03-09] | 167.4 M | 1,691.1 M |
| Filed 2025-09-05 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| VC | Affinity Healthcare Special SG LP | [2021-03-09] | 2.2 M | 3.5 M |
| Offered $2,155,000 · Filed 2020-08-12 (D) · Exemption 506(b), 3(c), 3(c)(1) · Duration One year or less · Revenue Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 2 | 1,691.1 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 2 | 1,691.1 |
| By Discretionary | ||
| Discretionary | 2 | 1,691.1 |
| Non-Discretionary | 0 | 0.0 |
| Total | 2 | 1,691.1 |
| By Non-United States Persons | ||
| Non-United States Persons | 392.1 | |
| United States Persons | 1,299.0 | |
| Total | 2 | 1,691.1 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Jonathan Chu | Executive Officer | 13 | 2 | |
| Andrew Weinstein | Executive Officer | 6 | 2 | |
| Michael Cho | Executive Officer | 6 | 2 | |
| Affinity Asset Advisors LLC | Executive Officer, Promoter | 4 | 2 | |
| Affinity Healthcare GP LLC | Executive Officer | 2 | 2 | |
| Affinity Healthcare Special GP II LLC | Executive Officer | 1 | 1 | |
| Affinity Healthcare Fund LP | Promoter | 1 | 1 | |
| Affinity Healthcare Special GP LLC | Executive Officer | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001773195] | |
| SC 13G | [0001773195] |
| Firm Profile (Form ADV) | |
|---|---|
| Discretionary AUM | $0.2B |
| Serves | Institutional |
| Fund Types | Hedge Fund |
| LEI | 549300307G5AWN6LYD87 |
| Comparable Firms | State | AUM |
|---|---|---|
|
Engine Capital Management LP
✚
|
NY | 1,725.5 M |
|
RK Capital Management LLC
✚
|
FL | 1,719.0 M |
|
Broadwood Capital Inc
✚
|
NY | 1,711.4 M |
|
North Peak Capital Management LLC
✚
|
NY | 1,703.0 M |
|
Prescott General Partners LLC
✚
|
FL | 1,694.9 M |
|
Parsifal Capital Management LP
✚
|
CT | 1,694.4 M |
|
ADAR1 Capital Management LLC
✚
|
TX | 1,675.1 M |
|
Quantitative Investment Management LLC
✚
|
VA | 1,670.6 M |
|
FORA Capital LLC
✚
|
FL | 1,665.4 M |
|
Philosophy Capital Management LLC
✚
|
CA | 1,663.1 M |